It is unclear whether a random plasma cortisol measurement and the corticotropin (ACTH) test adequately reflect glucocorticoid secretory capacity in critical illness. This study aimed to determine whether these tests provide information representative of the 24 hour period.
Relative adrenal insufficiency is thought to be a frequent problem in critically ill septic patients 1, 2 . Low plasma cortisol levels and impaired responses to corticotropin (ACTH) have been reported with varying frequencies (0-41%) in critically ill patients 3, 4, 5 . High plasma cortisol and a relatively low response to corticotropin have also been reported. Data based on ran-dom cortisol and the response to corticotropin have been used to prognosticate outcome in sepsis 6 .
Whilst some reports demonstrate higher mortality associated with putative adrenocortical insufficiency 3, 4, 6, 7 others have cast doubt on this association 8, 9 . An important reason for this conflict is the difficulty in confidently diagnosing adrenocortical insufficiency in the critically ill. A number of controversies exist regarding the assessment of adrenocortical insufficiency in the critically ill.
Firstly, random plasma cortisol, the response to ACTH or both have been used. It is not clear whether a random cortisol adequately reflects the 24 hour adrenal secretory profile. In the intensive care unit, several factors such as light, sound and sleep interruption may disrupt the circadian rhythm of cortisol secretion 10, 11, 12 . Assessment of cortisol secretion under these conditions would require sequential evaluation to determine optimal time periods for sampling. The biological half-life of cortisol is 90 minutes 13 . Thus longer sampling intervals may potentially miss significant peaks and troughs. Other important considerations include examining cortisol data in relation to the common triggers for cortisol release such as hypoxia, hypotension and hypoglycaemia 12, 14, 15 .
The second area of controversy surrounds the dose of corticotropin to be used. The use of the 250 µg dose has been criticized because it results in supraphysiological concentrations of corticotropin and therefore may miss mild secondary adrenal insufficiency. The 1.0 microgram dose more closely approximates physiological concentrations of ACTH in the plasma 16 . In healthy volunteers, the 30-min cortisol response to 1 µg has been shown to be similar to the 250 µg dose. However, the 60-min response to 1.0 µg was significantly lower (549±61 vs 842± 110 nmol/l). Whilst the low dose test has been shown to be more sensitive in the HIV infected critically ill patient population 17 , there are minimal data in the septic critically ill population 25 .
Furthermore, over 90% of circulating cortisol is bound to plasma proteins, particularly cortisol binding globulin 13 . Most studies report total plasma cortisol rather than the physiologically important free cortisol. Finally, to determine the integrity of the hypothalamo-pituitary-adrenal (HPA) axis, one needs to measure concomitant plasma ACTH concentrations.
A search of the literature identified only two studies which examined serial plasma cortisol measurements in critically ill patients 14, 18 . However information on the triggers for steroid release and the corticotropin response, plasma ACTH and free cortisol were not collected 14 .
To clarify some of the above issues, we prospectively studied a group of critically ill patients with sepsis to: a) characterize the typical temporal profile of cortisol secretion in critically ill patients by performing hourly measurements over a 24 hour period, b) establish if optimum sampling times for random cortisol could be determined from the temporal profile, c) determine if a random cortisol and the response to a low dose corticotropin test are representative of the 24 hour period, d) assess the integrity of the hypothalamo-pituitaryadrenal axis axis by performing plasma ACTH measurements, and e) examine urinary free cortisol concentrations to delineate the relationship between total and free cortisol.
MATERIALS AND METHODS
The Ethics Committee of the Royal Brisbane Hospital approved the study and informed consent was obtained from patients' next of kin. Critically ill patients between the ages 18 and 65 years with a diagnosis of sepsis syndrome 19 admitted to the Intensive Care Unit were eligible for recruitment into the study. All patients were studied between Days 3 and 4 of admission to the Intensive Care Unit. Patients using or requiring glucocorticoid therapy or those with a history of diabetes mellitus, adrenal or pituitary disease, malignancy, renal failure or requiring operative intervention were excluded from the study. None of the patients received etomidate or ketoconazole. All patients in the ICU had continuous ECG and invasive arterial pressure monitoring as part of standard clinical practice. When patients required sedation for intensive care procedures, facilitation of positive pressure ventilation or transport, propofol (1-3 mg/kg/hour) in combination with alfentanil (10-20 µg/kg/hour) or midazolam (0.1-0.2 mg/kg/hour) in combination with fentanyl (1-2 µg/kg/hour) were used. Endotracheal intubation was performed and positive pressure ventilation initiated when clinically indicated.
Data Collection
Demographic data, APACHE II 20 and Sepsis related Organ Failure Assessment (SOFA) scores 21 were collected on the day of the study. Mean arterial pressure (MAP), arterial oxygen saturation (SpO 2 ), temperature and plasma glucose were measured hourly. Plasma cortisol measurements were performed on samples from arterial blood at hourly intervals for 24 hours commencing at 0500 h on day 1 and ending at 0400 h on day 2. Residual serum was frozen for analysis of ACTH at time points corresponding to the maximum and minimum measured cortisol levels, thus resulting in two samples per patient. At the end of the 24-hour study period patients received intravenous low dose (1 µg) corticotropin and plasma samples collected at 30 (0430) and 60 minutes (0500) for cortisol assays. Cumulative urine collections every six hours were collected into boric acid bottles and analysed for urinary free cortisol.
Biochemical Assays
Plasma glucose levels were measured with an ABL 620 blood gas analyzer. Plasma cortisol was measured by a competitive chemiluminescent immunoassay using a rabbit anti-cortisol antibody (Ciba Corning ACS). The coefficients of variation at cortisol levels of 80 nmol/l, 467 nmol/l and 855 nmol/l were 11%, 9% and 10% respectively. ACTH was measured by a solid-phase, two site sequential chemiluminescent immunometric assay. The coefficients of variation at ACTH levels of 80 ng/l, 239 ng/l and 901 ng/l are 10%, 6% and 6% respectively. Urinary free cortisol was assayed by HPLC.
Criteria for Adrenal Insufficiency
We examined three sets of criteria used for the diagnosis of adrenal insufficiency: These included: a) random cortisol levels of <200 nmol/l b) for the 1.0 microgram corticotropin test, an increase in plasma cortisol of <200 nmol/l at 30 min and although the "adequate 60 min plasma cortisol values" after 1 µg corticotropin have not been established, we used the traditional increase in cortisol by 250 nmol/l as the cutoff value as reported for the 250 µg dose. c) stress cortisol of <550 nmol/l.
Statistical Analysis of Data
Statistical analysis of the data was performed by a professional biostatistician at the Department of Public Health and Epidemiology, Queensland University of Technology. Data were analysed using SPSS for Windows Software Version 11.0. Where appropriate, the mean and standard deviations are presented. To examine for the presence of circadian rhythms in plasma cortisol, a regression model was fitted, and the strength of linear relationship between plasma cortisol and time was estimated. This model was fitted using a generalized estimating equations approach, assuming an independent working correlation matrix (imposing the least underlying assumptions), and accounted for the repeated nature of the observations per patient as well as adjusting for sex of patient. Similar analyses were applied to plasma glucose, mean arterial pressure and temperature. To determine the impact of the sampling time on cortisol concentrations, a variance decomposition analysis was performed. Regression analysis was used to examine the relationship between sickness severity and variability in hormonal secretion and between plasma and urinary free cortisol. The relationship between the maximal spontaneous hourly increase in cortisol was compared with the increase induced by corticotropin both at 30 minutes and at 60 minutes using both correlation coefficient and a paired t-test.
RESULTS
Twenty-four patients were enrolled into the study, of whom three were excluded from analysis because of a need for emergency operation during the study (1), withdrawal of consent through the study (1) and incomplete data collection (1) . The demographic data are outlined in Table 1 and the individual patient  diagnostic data are outlined in Table 2 .
Haemodynamic, Glucose, Oxygenation and Temperature Data
There was negligible variation in blood pressure (P=0.50) ( Figure 1 ), plasma glucose concentrations (P=0.54) ( Figure 2 ) and temperature during the study period (P=0.54). The mean MAP was maintained at 90 mmHg and the SpO 2 was above 90% throughout the study period. There were no hypoglycaemic episodes.
Plasma Cortisol Concentrations
Cortisol concentrations are reported as nmol/l; to convert to µg/dl, 1 µg/dl=27.6 nmol/l. The individual minimum, maximum and mean plasma cortisol over the 24-hour period for each patient is illustrated in Figure 3 . The individual mean plasma cortisol concentrations ranged from 286±59 nmol/l to 796± 83 nmol/l. The overall mean plasma cortisol (the mean of means) for the entire cohort was 457± 145 nmol/l. There was hour to hour variability (coefficient of variation 8-30%) in plasma cortisol concentrations. No circadian rhythm was demonstrable.
To determine optimum sampling times for cortisol, we first quantified the extent of variance attributable to the hour of measurement. Based on a variance decomposition analysis, only 0.01% of the variance was attributable to hour of measurement suggesting that variability is driven by individual variability. Consequently establishing an optimum sampling time for cortisol is difficult.
The Low Dose Corticotropin Test
The corticotropin test was performed in 20 patients. Plasma cortisol was measured at 30 min after corticotropin in 17 of the 20 patients, and at 60 min in all 20 patients. At 30 min the mean rise in plasma cortisol was 151±116 nmol/l. Only four patients demonstrated an increase >200 nmol/l at 30 minutes (the criterion for adrenal insufficiency after 1 µg corticotropin). A plasma cortisol increase of >250 nmol/l at 60 minutes after corticotropin was found in only two (9%) subjects. At 60 minutes, the mean rise in plasma cortisol from baseline was 136±133 nmol/l. From the hourly measurements of cortisol, the maximal spontaneous hourly rise was compared with the corticotropin-induced rise. The mean maximal spontaneous hourly rise in cortisol was 233±121 nmol/l, significantly greater than the corticotropin-induced rise (136±133 nmol/l, P<0.001). In 15 patients the maximal spontaneous hourly increase in plasma cortisol was greater than that induced by corticotropin ( Fig. 4 ). There was no significant difference in the mean plasma cortisol concentrations between responders (423±284 nmol/l) and non re-sponders to corticotropin (474±207 nmol/l, P=0.66). A comparison of corticotropin responses from our study with previously published data is provided in Table 3 .
Random cortisol measurement and the corticotropin response as a reflector of the 24 hour steroid secretory profile?
We used the 24 hour mean plasma cortisol value as a marker of adequacy of glucocorticoid secretion. As expected by statistical definition, there was a strong correlation between the mean cortisol and hourly random cortisol at any time during the 24-hour period ranging from an r 2 between 0.65 to 0.9, P<0.0001.
Similarly, the individual plasma cortisol responses to corticotropin at 30 minutes and 60 minutes were also correlated with the corresponding 24 hour mean cortisol (r 2 =0.72, P<0.001 and r 2 =0.51, P<0.001 respectively).
Urinary Free Cortisol
Seventeen patients demonstrated elevated 24-hour urinary free cortisol excretion. The mean 24 hour urinary free cortisol excretion was 865±937 nmol (normal 100-300). There was a weak correlation between total plasma cortisol and urinary free corti- sol (r 2 =0.36, P<0.01) ( Figure 5 ). UFC excretion was elevated in both corticotropin responders (1098±891 nmol) and non-responders (826±1392 nmol) and there were no significant differences between the two groups (P=0.77). Plasma ACTH Six patients demonstrated elevations in plasma ACTH. The mean ACTH concentrations ranged from 10-383 ng/l (normal reference range 10-50). No significant relationship was demonstrable between peak ACTH and total plasma cortisol (r=0.03) and peak ACTH and urinary free cortisol (r=0.03). The individual patient hormonal data are presented in Table 4 .
Limitations of diagnosing hypoadrenalism based on random cortisol, the corticotropin test and stress cortisol values
Many diagnostic thresholds have been suggested for random cortisol and the corticotropin test as indicative of hypoadrenalism, but none is entirely satisfactory 22, 23 . Depending on the time of sampling for random cortisol and the performance of the low dose corticotropin test, individual subjects could have been classified as either euadrenal or hypoadrenal. To consider this in more detail:
Three patients had at least one random plasma cortisol value <200 nmol/l (one criterion for hypoadrenal state) at some time during the day, although the remainder of their values were >200 nmol/l.
Sixteen patients met at least one criterion for adrenal insufficiency at 30 or 60 min on the corticotropin tests. However, 35% of non-responders had spontaneous hourly rises >250 nmol/l, thus highlighting the limitations of a single point corticotropin test.
Seventeen patients had at least >50% all of their hourly values <550 nmol/l and only four patients had the majority of values >550 nmol/l. Of the latter, only one patient had all values >550 nmol/l. Thus using 550 nmol/l as a criterion, a random cortisol would Plasma cortisol is expressed in nmol/l, UFC is in nmol/24 hours, and ACTH is reported in ng/ml. have led to the diagnosis of hypoadrenalism in 95% of patients. There were no significant differences in these two groups with respect to the corticotropin response.
None of the patients who would have been diagnosed as hypoadrenal based on either random plasma cortisol (using conventional or the stress cortisol criteria) or the corticotropin test manifested haemodynamic instability or laboratory features of hypoadrenalism.
Relationship Between Severity Scoring and Plasma Cortisol
No significant correlation was demonstrable between APACHE II score and mean plasma cortisol (r 2 =0.07) and SOFA scores and mean plasma cortisol (r 2 =0.01). There were significant negative linear correlations between the APACHE and the SOFA scores and plasma cortisol variability (P<0.001 in both cases). There was no difference in the plasma cortisol response to corticotropin between survivors and nonsurvivors.
DISCUSSION
The cardinal findings of our study are the lack of a circadian rhythm, marked hourly variability in cortisol secretory pattern and raised urinary free cortisol excretion in the group overall. A precise time period for sampling for random cortisol could not be established because of the marked hourly variability. Finally, we have also demonstrated the potential limitations of a random cortisol and the corticotropin response.
Cortisol Secretory Profile
The marked variability in cortisol secretion may stem from rhythmic discharge of ACTH from the pituitary. Although common triggers for ACTH release did not demonstrate marked changes in this study, other mediators of the systemic inflammatory response syndrome could have contributed to ACTH fluctuations. The lack of a strong correlation between ACTH and total plasma cortisol may be explained by the likely normal to raised plasma free cortisol concentrations and in part by the likelihood of ACTH resistance in critically ill patients 24 .
Urinary Free Cortisol
The elevation in urinary free cortisol levels suggests elevated plasma free cortisol. The dissociation between total plasma cortisol and urinary free cortisol as found in our study (weak correlation, r 2 =0.36) may be explained by the reported low cortisol binding globulin levels after septic shock and trauma 22, 24 or altered cortisol binding globulin affinity from displacement of cortisol by acidosis. Support for the notion of elevated plasma free cortisol levels in intensive care patients comes from a recent study 26 which demonstrated that in patients with hypoproteinaemia serum total cortisol levels were reduced, whereas the serum free cortisol levels were in fact elevated. The authors suggested that a baseline free cortisol level of 55.2 nmol/l (2.0 µg/dl) be considered as a threshold that identifies patients at risk for adrenal insufficiency during critical illness and that the corticotropin-stimulated serum free cortisol concentration of 85.3 nmol/l (3.1 µg/dl) or greater defines a normal response in critically ill patients. They also concluded that the increase in glucocorticoid secretion in critical illness is not discernible, when only the total cortisol concentration is measured, particularly in patients with hypoproteinaemia. A review of the serum albumin data ( Table  4 ) indicated significant hypoalbuminaemia in our study cohort which will fit in with the elevated free cortisol hypothesis.
Caveats in diagnosing hypoadrenalism based on a random cortisol and/or the corticotropin test
Although random cortisol and corticotropin responses may reliably reflect adrenal secretory capacity, caution needs to be exercised when inferring hypoadrenalism based on one measurement. Firstly the gold standard for relative adrenal insufficiency in critical illness has not been established. Secondly, as plasma cortisol is secreted in a pulsatile manner, plasma measurements at other times of the day may reveal a euadrenal concentration. Thirdly, the levels of urinary free cortisol were not significantly different between corticotropin responders and nonresponders suggesting comparable concentrations of plasma free cortisol in both groups. This finding prompts us to speculate that as the free cortisol is the biologically active hormone, inference on adrenal sufficiency should be based on the free rather than the total plasma cortisol. Further support for this argument comes from the finding that no patient who may have been classified as "hypoadrenal" demonstrated haemodynamic instability or laboratory features of hypoadrenalism.. Further difficulties are presented by variations in accuracy of cortisol assays. The coefficient of variation of cortisol estimations is usually 10-12%, thus the true cortisol level may lie within -20% to +20% of the result given. The same plasma submitted to different assays can return significantly different levels 23 . Thus cutoff levels determined by other assays may not be relevant to another institution.
Taking into account all of these factors, we suggest that if the random cortisol and corticotropin tests indicate a hypoadrenal situation, we advocate repeating the measurements after a discrete interval to get a "feel" for the cortisol profile before commencing steroids. This proposal needs to be the subject of future studies.
Plasma ACTH
Full assessment of the integrity of the hypothalamus-pituitary-adrenal axis requires concomitant measurement of plasma ACTH and cortisol concentrations. The normal reference range for plasma ACTH concentrations is 10-50 ng/l. Primary hypoadrenal states are characterized by low plasma cortisol and high ACTH levels, whilst secondary hypoadrenalism is typified by both low plasma cortisol and ACTH concentrations. There are few studies examining plasma ACTH in critically ill patients. In our study, no discernible relationship was observed between plasma ACTH and cortisol responses. In view of the paucity of data on ACTH in critically ill patients, no diagnostic criteria have been developed based on plasma ACTH concentrations to diagnose adrenal insufficiency in the critically ill. Furthermore, plasma ACTH has a half-life of 10 minutes. This combined with the technical difficulties in processing specimens for ACTH assay have relegated this investigation to the background in the critically ill patient.
Critique of the Study
Whilst it would have been desirable to have a cohort of patients with proven adrenal insufficiency, this population would not be representative of the typical ICU patient. We therefore used patients with a diagnosis of sepsis syndrome in whom there is a demonstrable incidence of adrenal insufficiency. Consequently a majority of our patients might have been euadrenal. Nevertheless, the results demonstrate the potential for mislabelling of these patients as hypoadrenal using current testing and criteria.
It could be argued that there was no gold standard such as provocative testing in these patients. Hypotension and hypoglycaemia are potent stimuli for adrenal stimulation. We therefore set out to look for a significant relationship between changes in these variables and cortisol levels and could not demonstrate any owing to the stability of MAP and plasma glucose. Despite this, ours is the first study to have examined changes in plasma cortisol in relation to these stressors.
Was the use of 24 hour mean plasma cortisol as an indicator of the adequacy adrenal secretory capacity justified? We reasoned that of the available measurements, the mean value of 24 samples provides a global assessment of the cortisol profile in each patient. To our knowledge this is the first study which has examined cortisol data in this regard and we submit that there are no studies to argue for or against the use of this measure.
Were the patients in our study adequately stressed? Despite the presence of sedation and analgesia, most of our patients had positive pressure ventilation, moderately elevated APACHE II and SOFA scores and were critically ill suggesting a moderate level of stress during the study period.
We also submit that enrolment of patients between Day 3 and 4 may only provide partial insight into this complex problem. We chose this time period because patients may have gone past their acute resuscitation phase and may be beginning to demonstrate features of evolving systemic inflammatory response syndrome and multiorgan dysfunction states. However, a follow-up assessment would allow a more detailed assessment of the cortisol secretory profile, which will be the subject of future investigations.
Finally, what constitutes an appropriate stress cortisol 25 and the response to corticotropin in the critically ill patient remains controversial. The results from this study clearly demonstrate that irrespective of whatever threshold value of plasma cortisol is chosen (whether unstressed or stressed plasma cortisol values), this study highlights the need for caution when interpreting a single plasma cortisol.
We conclude that although random cortisol measurements and the low dose corticotropin tests reliably reflect the 24 hour mean cortisol in critical illness, they do not take into account the pulsatile nature of cortisol secretion. Consequently, there is the potential for erroneous conclusions about adrenal function based on a single measurement. We therefore suggest repeating measurements after a discrete interval. We further suggest that plasma free cortisol 26 may be more relevant than total plasma cortisol in the assessment of adrenal function in critical illness and that this should be the subject of future investigations. ment in the data collection and analysis, interpretation of data in the writing of the report.
